MK-0663/Etoricoxib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-0663/Etoricoxib, covering 2020-04-07 to 2020-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098) [Phase 3]